Lam AM, Espiritu C, Bansal S, Micolochick Steuer HM, Zennou V, Otto MJ, Furman PA. . Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resis. J Virol. . 2011. 85(23). 12334-12342 . Find at Google Scholar.
Ali S, Leveque V, Le Pogam S, Ma H, Philipp F, Inocencio N, Smith M, Alker A, Kang H, Najera I, Klum. Selected replicon variants with low-level in vitro resistance to the hepatitis C virus NS5B polymera. Antimicrob Agents Chemother . 2008. 52(12) . 4356-4369. Find at Google Scholar.
Tong X, Le Pogam S, Li L, Haines K, Piso K, Baronas V, Yan JM, So SS, Klumpp K, Najera I. . In vivo emergence of a novel mutant L159F/L320F in the NS5B polymerase confers low-level resistance . J Infect Dis. . 2014. 209(5). 668-675. Find at Google Scholar.
Gane EJ, Stedman CA, Hyland RH, Ding X, Svarovskaia E, Subramanian GM, Symonds WT, McHutchison JG, P. Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5. Gastroenterology . 2014. 146(3). 736-743. Find at Google Scholar.
Tong X, Le Pogam S, Li L, Haines K, Piso K, Baronas V, Yan JM, So SS, Klumpp K, Najera I. . In vivo emergence of a novel mutant L159F/L320F in the NS5B polymerase confers low-level resistance . J Infect Dis. . 2014. 209(5). 668-675. Find at Google Scholar.